P127 the SLE-DAS Enables Easy Identification of SLE Patients with Moderate-to-severe Disease Activity and Worse HR-QoL in the Screening for SLE Clinical Trials: a Post-Hoc Study in the Phase 2 and 3 Anifrolumab Trials
Lupus Science and Medicine（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined